top of page
.png)
Eyes on Pharma
Check-out What Intel Caught our Eye
Eyes On Clinical Data & FDA News: Huntington's, Psoriasis, PTSD, MASH, and Autism
Lately we've had Eyes On: Clinical Data, FDA news, M&A, and more. Read more about uniQure's AMT-130 data for Huntington's Disease, Roche's acquisition of 89bio for MASH, JnJ's Iconic Advance Data for Psoriasis, Lundbeck's CRL letter for PTSD, and the latest buzz around acetaminophen.
Jana Chisholm
Oct 1911 min read
Eyes On Alzheimer's, Epilepsy, Immunology, and Obesity
This week, we had eyes on data readouts, launch metrics, M&A, and more. Catch up with the news from Roche, AstraZeneca, Lundbeck, and AbbVie
Jana Chisholm
Nov 30, 20245 min read
Eyes On October M&A activities, Approvals, and more
Last month, we had Eyes On some of the latest approvals, M&A and litigation. Read more about AbbVie, Genentech, Lundbeck, and GSK ...
Jana Chisholm
Nov 1, 20245 min read
bottom of page